Creation and Assessment of the Visual Medical Scale for Measuring Nail Psoriasis Severity (ViSENPsO®)
Clinical Scorecard: Creation and Assessment of the Visual Medical Scale for Measuring Nail Psoriasis Severity (ViSENPsO®)
At a Glance
| Category | Detail |
|---|
| Condition | Nail Psoriasis |
| Key Mechanisms | Impacts nail matrix and bed, causing pain and reduced hand function. |
| Target Population | Patients with psoriasis, particularly those with nail involvement. |
| Care Setting | Clinical trials and dermatology practices. |
Key Highlights
- ViSENPsO provides a standardized, user-friendly assessment tool.
- Addresses limitations of existing tools like NAPSI in precision and reliability.
- Developed through qualitative and quantitative analysis involving dermatologists and patients.
- Supports improved consistency in nail psoriasis severity evaluation.
- Further validation needed in larger, diverse populations.
Guideline-Based Recommendations
Diagnosis
- Use ViSENPsO for consistent severity scoring in clinical settings.
Management
- Incorporate ViSENPsO in clinical trials to evaluate treatment efficacy.
Monitoring & Follow-up
- Regularly assess nail psoriasis severity using ViSENPsO to track treatment response.
Risks
- Potential for underrepresentation of disease nuances with simplified tools.
Patient & Prescribing Data
Patients with nail psoriasis, particularly those with concurrent plaque psoriasis.
ViSENPsO may enhance understanding of treatment benefits and patient quality of life.
Clinical Best Practices
- Utilize ViSENPsO in clinical trials for standardized assessment.
- Engage patients in discussions about their perceptions of nail psoriasis severity.
Related Resources & Content
